Welcome to Blood Cancer United Newsroom
Get the latest news about how we are creating a world without blood cancers—and improving the quality of life of patients and their families.
Research
The First Annual LLS CDP Achievement Award Winners
The Leukemia & Lymphoma Society (LLS) has supported junior investigators in blood cancer research for more than 50 years through the Career Developmen…
Research
Coordination of Distinct Pathways Drives AML in a Subset of Patients
Various cellular events may lead to cancer. These include DNA mutations that change a protein’s structure as well as alterations that change the way g…
Research
Dr. Shannon Elf: CDP Special Fellow Achievement Award Winner
Dr. Shannon Elf, rising star in the blood cancer field, is a highly driven and compassionate investigator dedicated to the pursuit of new therapeutic …
Research
Caregiver Support May Lead To Better Outcomes For Both Patients And Caregivers
It goes without saying that cancer causes a great burden on the patient, but few consider the great burden it causes on the informal caregivers. An i…
Research
Dr. Peter van Galen: CDP Fellow Achievement Award Winner
The winner of the first annual CDP Achievement Award in the Fellow category, along with $10,000 to be used for LLS mission-relevant research, is Dr. P…
News
LLS Statement on Inauguration Day 2021
February 18, 2021 Our right to vote is the heart of our democracy, as is a free and fair election. The democratic process is critical to our work at T…
Patient organizations applaud strong actions to protect people with pre-existing conditions
“President Biden’s actions this week represent a significant first step towards improving access to high-quality health coverage for people with pre-e…
News
FDA Approval of New CAR T-Cell Therapy Further Solidifies Immunotherapy as a Mainstay in Cancer Treatment
The U.S. Food and Drug Administration (FDA) today announced approval of a new CAR T-cell treatment for adult patients with certain forms of relapsed/r…
NexImmune Announces Pricing of Upsized Initial Public Offering
NexImmune, Inc., a clinical-stage biotechnology company developing a novel approach to immunotherapy designed to employ the body’s own T cells to gene…
News
Burlington Stores & Its Customers Raise Nearly $4 Million for The Leukemia & Lymphoma Society (LLS) in the Fight Against Blood Cancer
The Leukemia & Lymphoma Society (LLS), the global leader in the fight against blood cancer, and Burlington Stores, the national retailer delivering am…
For all media-related inquiries and interview requests please email
mediarelations@bloodcancerunited.org
A Blood Cancer United representative will respond as soon as possible.
